EUCRISA

Indicated For

Mild-to-moderate atopic dermatitis

About This Medication

# Pfizer Dermatology Patient Access Program Patient Guide: How to Get EUCRISA (crisaborole) at Low or No Cost EUCRISA (crisaborole) is a prescription ointment used to treat mild to moderate eczema (atopic dermatitis) in adults and children 3 months and older. The **Pfizer Dermatology Patient Access Program** helps eligible patients with commercial insurance get EUCRISA at low or no cost by covering out-of-pocket expenses like copays, coinsurance, or deductibles, depending on your specific coverage. ## About EUCRISA and When It's Used **EUCRISA** is a nonsteroidal topical phosphodiesterase 4 (PDE4) inhibitor that works by reducing inflammation and itchiness associated with eczema flare-ups. Unlike steroid creams, it doesn't thin the skin with long-term use, making it suitable for sensitive areas like the face or folds. Apply a thin layer twice daily to affected skin. Common side effects include burning or stinging at the application site. Always follow your doctor's instructions and report any severe reactions. This program is specifically for Pfizer dermatology medications like EUCRISA, providing support through benefits investigation, prior authorization help, and cost assistance. It's available only in the U.S. and Puerto Rico. ## Who Qualifies for the Program? To qualify, you must: - Have a valid prescription for EUCRISA from a U.S.-licensed healthcare provider for an FDA-approved condition (like atopic dermatitis). - Be enrolled in the program by completing and submitting the required forms. - Meet insurance requirements: **Commercial prescription drug insurance is required**. You are **not eligible** if you have Medicare, Medicaid, other federal or state-funded programs, or no insurance. Commercially insured patients without coverage changes may check a box on the form. - Provide proof of income for assistance evaluation (details below). - Sign consent forms allowing Pfizer to communicate with you and your insurer. Your doctor or office staff can help start the process right after writing your prescription. ## Income Eligibility Breakdown Specific income thresholds (e.g., Federal Poverty Level percentages) are **not publicly disclosed** in program details. Eligibility requires proof of income, and the program evaluates on a case-by-case basis. Patients must certify they cannot afford their medication. Here's a general overview based on available information: | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not disclosed | Proof of income required (e.g., W2, tax return, paystub) | | Couple | Not disclosed | Case-by-case evaluation | | Family of 3 | Not disclosed | Certify inability to afford medication | | Family of 4+ | Not disclosed | Updated info may be needed annually | **Notes**: Contact the program at **(844) 382-7472** or visit the [patient access site](https://www.eucrisa.com/pfizer-derm-patient-access) for your personalized eligibility. Reapplying patients may skip some insurance updates if unchanged. ## Insurance Requirements - **Required**: Valid commercial (private) insurance covering prescriptions. - **Not Eligible**: Medicare, Medicaid, VA, Tricare, or other government programs. - The program conducts a **benefits investigation** to check your coverage, copay, out-of-pocket max, and prior authorization (PA) needs. Some plans require PA for EUCRISA— the team can help research and submit. - Provide insurer details: copayment after PA (if needed), OOP maximum. ## Step-by-Step Application Process 1. **Get Prescribed**: Ask your doctor for EUCRISA. They complete **page 4** of the enrollment form (prescriber section). 2. **Download or Get the Form**: From [https://www.eucrisa.com/pfizer-derm-patient-access](https://www.eucrisa.com/pfizer-derm-patient-access) or your doctor's office. Fill out patient sections (pages 1-3): personal info, insurance, income proof. 3. **Sign Consents**: Sign HIPAA authorization and consent to share health info/personal data. This is **mandatory**—do it in-office, via patient portal (PfizerDermatologyPatientPortal.com), or by phone. 4. **Submit**: - **Fax**: 1-877-548-1734 (include cover sheet). - **Online**: Pfizer PAP Connect or patient portal. - **Phone Help**: (844) 382-7472 or 1-833-956-3376 (Mon-Fri, 8AM-8PM ET). - Mail option also available. 5. **Confirmation**: Expect a **call or text** from 1-833-956-3376 to verify enrollment. Answer it! 6. **Benefits Investigation**: Program checks insurance and handles PA/appeals if needed. 7. **Approval**: If eligible, medication ships to your pharmacy or directly (details follow up). Your doctor can e-prescribe to Sonexus Health Pharmacy (NCPDP: 5910206). ## Timeline and Delivery - **Enrollment Confirmation**: Within days via call/text. - **Processing**: Varies; initial dispense must be within **60 days** of enrollment. Appeals within 60-180 days if denied. - **Annual Review**: After 12 months, submit updated prescription and benefits investigation. - **Delivery**: Typically to your chosen pharmacy. Track status via patient portal. - Support available Mon-Fri 8AM-8PM ET. ## Alternatives if Denied or Ineligible - **Appeal**: Submit payer-required appeals within timelines (program helps). Two appeals within 180 days may be needed for continued eligibility. - **Other Pfizer Programs**: Check PfizerRxPathways.com Program Finder for broader assistance. - **General Options**: - GoodRx or SingleCare for discounts. - NeedyMeds.org or RxAssist.org for other PAPs. - Patient Access Network (PAN) Foundation for copay help. - Talk to your doctor about generic alternatives or samples. - If insurance changes, request new benefits investigation. ## Disclaimer This guide is for informational purposes only and based on publicly available program details as of 2026. Eligibility, benefits, and terms can change—**always verify directly with Pfizer Dermatology Patient Access at (844) 382-7472 or your healthcare provider**. Pfizer may update requirements. This is not medical advice; consult your doctor for treatment decisions. Program not valid where prohibited by law. Assistance limited to U.S./Puerto Rico residents. Word count: 1028.

Program information last verified: March 30, 2026